{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:47:20Z","timestamp":1793054840994,"version":"4.5.0"},"reference-count":38,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Hereditary hemorrhagic telangiectasia (HHT) is the second\u2010most common inherited bleeding disorder worldwide, afflicting one in 4000\u20135000 people, and is the most morbid inherited bleeding disorder of women. HHT causes recurrent severe epistaxis, chronic gastrointestinal bleeding, heavy menstrual bleeding, and arteriovenous malformations in the lung, liver, and brain that cause serious bleeding and nonbleeding complications. There are no approved treatments worldwide, and the direct medical costs of HHT have not been well\u2010characterized. We utilized the Komodo Healthcare Map claims database to create a large sample of US patients diagnosed with HHT, including a subgroup with anemia and a subgroup receiving hematologic support (iron infusions and\/or red cell transfusions). We quantified mean per patient per year (PPPY) and total population inpatient, outpatient, and pharmacy costs in 2022 and 2023. The mean PPPY costs for all HHT patients (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200924\u2009407;\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200923\u2009524), those with anemia (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200913\u2009856;\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200913\u2009192) and those receiving hematologic support (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20096191;\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20095818) were approximately $19\u2009000, $27\u2009000, and $40\u2009000, respectively, across years, representing &gt;\u2009$450\u2009000\u2009000 in annual healthcare costs in the sample. The leading cost drivers were related to treatment for bleeding and its consequences. While accounting for nearly 60% of HHT patients, those with anemia accounted for ~80% of direct medical costs. Across the majority of leading inpatient, outpatient, and pharmacy cost drivers, patients with anemia and anemia treatment accounted for 75%\u2013100% of cost. The PPPY costs of HHT are comparable to, or exceed, those of other rare, resource\u2010intensive serious diseases, including sickle cell disease, muscular dystrophy, and cystic fibrosis.\n                  <\/jats:p>","DOI":"10.1002\/ajh.27756","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T08:58:54Z","timestamp":1751446734000},"page":"1722-1735","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Characterizing the Healthcare Utilization and Costs of Hereditary Hemorrhagic Telangiectasia"],"prefix":"10.1002","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6175-1383","authenticated-orcid":false,"given":"Hanny","family":"Al\u2010Samkari","sequence":"first","affiliation":[{"name":"Division of Hematology Oncology Massachusetts General Hospital  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy J.","family":"Mayne","sequence":"additional","affiliation":[{"name":"Slipstream IT  Blue Bell Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misty","family":"Troutt","sequence":"additional","affiliation":[{"name":"Slipstream IT  Blue Bell Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant","family":"Patle","sequence":"additional","affiliation":[{"name":"Slipstream IT  Blue Bell Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Clancy","sequence":"additional","affiliation":[{"name":"Cure HHT  Monkton Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Duhaime","sequence":"additional","affiliation":[{"name":"Diagonal Therapeutics  Watertown Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011961"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572\u2010024\u201000585\u2010z"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.193003"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176379"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.7326\/m20\u20101443"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1288\/00005537\u2010199109000\u201000008"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24832"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572\u20100241.2000.01792.x"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001538"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.261859"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13714"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312749"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008739"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021765"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10456\u2010021\u201009807\u20104"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocpiqo.2020.08.010"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023\u2010021\u201002061\u20103"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2018.360"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16978"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15715"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1055\/s\u20100042\u20101743467"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024012589"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882\u2010022\u201002778\u20108"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2019.1588738"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.01.017"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2009.06.435"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.250"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023\u2010019\u20101239\u20106"},{"key":"e_1_2_9_30_1","article-title":"Congestive Heart Failure Is Strongly Associated With Hereditary Hemorrhagic Telangiectasia (HHT): Analysis of a Large National Database","volume":"5","author":"Farooqui M.","year":"2019","journal-title":"Neirology"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2010.08.046"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.109"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/147323001204000105"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007748"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023\u2010020\u201001579\u20102"},{"key":"e_1_2_9_36_1","unstructured":"K.Keisler\u2010StarkeyandL.Bunch \u201cHealth Insurance Coverage in the United States \u201daccessed March 21 2025 2024 https:\/\/www2.census.gov\/library\/publications\/2024\/demo\/p60\u2010284.pdf."},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/1945892419886756"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2352\u20103026(21)00164\u20102"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10081682"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.27756","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T06:59:58Z","timestamp":1766386798000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.27756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1002\/ajh.27756"],"URL":"https:\/\/doi.org\/10.1002\/ajh.27756","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"2025-04-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}